Deciphera Receives European Commission Approval Of Romvimza (Vimseltinib)

RefinitivMeno di 1 minuto di lettura

Ono Pharmaceutical Co Ltd 4528:

DECIPHERA RECEIVES EUROPEAN COMMISSION APPROVAL OF ROMVIMZA™ (VIMSELTINIB) FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR (TGCT)

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Accedi o crea un account gratuito per leggere queste notizie